This drug successfully prevented IRF3 translocation to the nucleus (Figure 1C), but could not prevent G1-to-G0 transitioning, SAMHD1 dephosphorylation, and blockade of HIV-1 infection (Figures 1A–1C). This evidence concerns the gene IRF3 and HIV-1 infection.